Injectable Therapies - Core - CDEP

Not all diabetes injections are insulin. Some GLP-1 receptor agonists (such as Exenatide, Lixisenatide, Dulaglutide or Liraglutide) are also injected subcutaneously. Insulin is rated, globally, as one of the top 10 high risk medications. Insulin errors are, unfortunately, common. Insulin safety is of paramount importance due to the risk of hypoglycaemia, which if severe can be life-threatening. All healthcare professionals prescribing, training people with diabetes to inject insulin or administering insulin themselves should be fully competent in the safe use of insulin. TOPIC TIPS... You do not have to complete the topic in one go... CDEP is designed to be done in 'bite-sized chunks' fitting into your busy life! This topic generally takes around 50 minutes to 1 hour 45 minutes to complete depending on your chosen CDEP level - although this may differ from person to person. There are a number of sections (competencies) within this topic, each with its own set of resources that may be useful to review should you require further support. However, undertaking the section itself is part of the learning process and will confirm or improve your current level of knowledge around that specific section, so why not jump straight in and have a go... It may be helpful to have the BNF or a online prescribing portal open to help you when it comes to reviewing side effects, optimal timings and doses of the injectable therapies.